Saito Biotech (300583): Intermediates are expected to rise steadily, and the industrial chain is being extended and progressed steadily
Saito Biotech (300583): Building a full industry chain layout to accelerate the acquisition of Silver Valley Pharmaceuticals
Saito Biotech (300583): Steady layout and optimization of the asset structure of the pharmaceutical industry chain are expected to usher in valuation reshaping
Saito Biotech (300583): The API business is steady and the volume of respiratory preparations opens the growth ceiling
Saito Biotech (300583): The main business is stable, and there are additional proposed mergers and acquisitions of Class 1.1, and the synergy effect of large single products is remarkable
Seto Biology (300583) New share Analysis report: leading enterprises of steroid drug raw materials
[southwest Securities] Saito Biology: a leading enterprise of steroid drug raw materials
Seito Biology (300583) New share Research report: the Leader of technological Innovation in the steroid Drug Industry
[Haitong] Research report on Seto Biological New shares: the Leader of technological Innovation in the steroid Drug Industry
No Data
No Data